Drug Promotion During Pandemic: Website Links To Telemedicine Prescribers Require Caution

Growing trend of linking product websites to telehealth services raises regulatory concerns. Virtual interactions with healthcare providers might necessitate new FDA guidance, lawyers note at FDLI annual meeting.

Telemedicine
Drug site links to telemedicine providers raise promotion compliance concerns • Source: Alamy

A significant trend during the COVID-19 pandemic has been industry’s growing use of telemedicine prescribers, which has raised concerns about ensuring compliance in the promotion of drug products.

Lawyers discussed the potential problems of directing patients to a telehealth service via a product website at the Food and...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Marketing & Advertising

More from Compliance